BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Prostate
,
Nosology
,
Tamoxifen
,
rs3825942
,
SIRT1
,
T cell receptor signaling pathway
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
mg132
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
HMOX1
SLC7A11
GADD45A
ATF3
HSPA1A
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
organic cyclic compound metabolic process
heterocycle metabolic process
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Retinal pigment epithelial hTERT RPE-1 cells treated with Reversine, bafilomycin A1 or MG132
Heat shock response induced by both elevated temperature and a proteasome inhibitor
Embryonic fibroblasts with CHOP or ATF5 perturbations
Explore Curated Studies Results
Literature
Most Relevant Literature
Inhibition of rat liver cathepsins B and L by the peptide aldehyde benzyloxycarbonyl-leucyl-leucyl-l…
Centrosomal aggregates and Golgi fragmentation disrupt vesicular trafficking of DAT.
c-Myc down-regulation is involved in proteasome inhibitor-mediated enhancement of radiot…
MG132, a proteasome inhibitor, induces apoptosis in tumor cells.
Combination of quercetin and tannic acid in inhibiting 26S proteasome affects S5a and 20S expression…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
DC-STAMP & TRAF3: Regulators of Osteoclastogenesis and Biomarkers in PsA
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ